If youve been following GLP-1 news in 2025 and 2026, youve probably seen alarming headlines about the FDA cracking down on compounded semaglutide
First and foremost, every persons body is different
Steinert RE, Feinle-Bisset C, Asarian L, et al
Nat Commun 11 , 1272 (2020)
Primary research applications: In-vitro and pre-clinical models of skin regeneration, wound repair, hair-follicle biology, and tissue remodeling [3]
That includes understanding what the drugs do and dont do, the possible side effects, and what happens if they take the drug and then later go off it.3,4 As part of some research shes doing, Tewksbury is finding, anecdotally, that some patients do their own research before asking their provider about GLP-1s, while others say their doctor broached the subject